Creo Medical announced plans to sell its remaining 49% stake in its European division to the division's CEO, with the deal expected to complete within three months pending approvals. The company also plans to raise approximately £5.5 million through a share placing at a 31.9% premium, with directors and the Development Bank of Wales subscribing significant amounts. Full-year 2025 results showed strong revenue growth and reduced losses, and the company expects 2026 revenue growth between 50% and 60%. The stake sale and fundraising aim to simplify the group, strengthen the balance sheet, and fund the company until it reaches sustainable cash flow and profitability.
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
